Cover Image

Management of patients with acute promyelocytic leukemia

With the introduction of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) acute promyelocytic leukemia (APL) has become from a detrimental to one of the most curable malignant diseases in humans. In particular, the chemotherapy-free regimen with ATO/ATRA has been proven to be highly effecti...

Full description

Saved in:
Bibliographic Details
Main Authors: Kayser, Sabine (Author) , Schlenk, Richard Friedrich (Author) , Platzbecker, Uwe (Author)
Format: Article (Journal)
Language:English
Published: 24 April 2018
In: Leukemia
Year: 2018, Volume: 32, Issue: 6, Pages: 1277-1294
ISSN:1476-5551
DOI:10.1038/s41375-018-0139-4
Online Access:Verlag, Volltext: https://doi.org/10.1038/s41375-018-0139-4
Verlag: https://www.nature.com/articles/s41375-018-0139-4
Get full text
Author Notes:Sabine Kayser, Richard F. Schlenk, Uwe Platzbecker

MARC

LEADER 00000caa a2200000 c 4500
001 1684952018
003 DE-627
005 20230427200021.0
007 cr uuu---uuuuu
008 191210s2018 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41375-018-0139-4  |2 doi 
035 |a (DE-627)1684952018 
035 |a (DE-599)KXP1684952018 
035 |a (OCoLC)1341280903 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kayser, Sabine  |d 1979-  |e VerfasserIn  |0 (DE-588)138694923  |0 (DE-627)605256233  |0 (DE-576)30778813X  |4 aut 
245 1 0 |a Management of patients with acute promyelocytic leukemia  |c Sabine Kayser, Richard F. Schlenk, Uwe Platzbecker 
264 1 |c 24 April 2018 
300 |a 18 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.12.2019 
520 |a With the introduction of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) acute promyelocytic leukemia (APL) has become from a detrimental to one of the most curable malignant diseases in humans. In particular, the chemotherapy-free regimen with ATO/ATRA has been proven to be highly effective in de novo APL and has become standard first-line therapy in younger adult, non-high-risk patients. Nevertheless, early death is still a major issue in APL, particularly in older patients, emphasizing the need of rapid diagnostics and supportive care together with immediate access to ATRA-based therapy. Despite the dramatic progress achieved in therapy of APL challenging situations occur, particularly in patients excluded from controlled studies with clinical knowledge mainly based on case reports and registries. Rapid identification and treatment of newly diagnosed patients as well as the management of toxicities and complications remain challenging. We offer up-to-date information and guidance regarding treatment of APL. Based on a literature review of existing scientific evidence we also discuss the approach to high-risk, elderly, pregnant and pediatric patients, treatment in patients with renal failure as well as of therapy-related or relapsed/refractory APL. 
700 1 |a Schlenk, Richard Friedrich  |d 1965-  |e VerfasserIn  |0 (DE-588)129025380  |0 (DE-627)387778004  |0 (DE-576)297454102  |4 aut 
700 1 |a Platzbecker, Uwe  |e VerfasserIn  |0 (DE-588)115567089  |0 (DE-627)647686228  |0 (DE-576)337938695  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 32(2018), 6, Seite 1277-1294  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Management of patients with acute promyelocytic leukemia 
773 1 8 |g volume:32  |g year:2018  |g number:6  |g pages:1277-1294  |g extent:18  |a Management of patients with acute promyelocytic leukemia 
856 4 0 |u https://doi.org/10.1038/s41375-018-0139-4  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41375-018-0139-4  |x Verlag 
951 |a AR 
992 |a 20191210 
993 |a Article 
994 |a 2018 
998 |g 129025380  |a Schlenk, Richard Friedrich  |m 129025380:Schlenk, Richard Friedrich  |d 50000  |e 50000PS129025380  |k 0/50000/  |p 2 
998 |g 138694923  |a Kayser, Sabine  |m 138694923:Kayser, Sabine  |d 910000  |d 910100  |e 910000PK138694923  |e 910100PK138694923  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1684952018  |e 3562886357 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"18 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2008023-2"],"eki":["32046699X"],"issn":["1476-5551"]},"origin":[{"dateIssuedDisp":"1997-","dateIssuedKey":"1997","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}],"recId":"32046699X","language":["eng"],"note":["Gesehen am 15.03.04"],"disp":"Management of patients with acute promyelocytic leukemiaLeukemia","type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"1277-1294","issue":"6","year":"2018","extent":"18","text":"32(2018), 6, Seite 1277-1294","volume":"32"},"pubHistory":["Nachgewiesen 11.1997 -"],"title":[{"title":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title_sort":"Leukemia"}]}],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"24 April 2018"}],"id":{"eki":["1684952018"],"doi":["10.1038/s41375-018-0139-4"]},"name":{"displayForm":["Sabine Kayser, Richard F. Schlenk, Uwe Platzbecker"]},"note":["Gesehen am 10.12.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1684952018","title":[{"title":"Management of patients with acute promyelocytic leukemia","title_sort":"Management of patients with acute promyelocytic leukemia"}],"person":[{"given":"Sabine","family":"Kayser","role":"aut","display":"Kayser, Sabine","roleDisplay":"VerfasserIn"},{"display":"Schlenk, Richard Friedrich","roleDisplay":"VerfasserIn","role":"aut","family":"Schlenk","given":"Richard Friedrich"},{"family":"Platzbecker","given":"Uwe","display":"Platzbecker, Uwe","roleDisplay":"VerfasserIn","role":"aut"}]} 
SRT |a KAYSERSABIMANAGEMENT2420 

Similar Items